Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines

被引：0
|
作者：
Sevilay Batıbay
Rezan Koçak Ulucaköy
Zafer Günendi
Işıl Fidan
Gülendam Bozdayı
Feride Nur Göğüş
机构：
[1] Gazi University Hospital,Division of Rheumatology, Department of Physical Medicine and Rehabilitation
[2] Ministry of Health Ankara City Hospital,Department of Internal Medicine, Division of Rheumatology
[3] Gazi University Hospital,Medical Microbiology
来源：
Inflammopharmacology | 2022年 / 30卷
关键词：
Covid-19; SARS-CoV-2; Vaccine; CoronaVac; BNT162b2; Rheumatology; Inflammatory rheumatic disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2089 / 2096
页数：7
相关论文
共 50 条
  • [1] Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines
    Batibay, Sevilay
    Ulucakoy, Rezan Kocak
    Gunendi, Zafer
    Fidan, Isil
    Bozdayi, Gulendam
    Gogus, Feride Nur
    INFLAMMOPHARMACOLOGY, 2022, 30 (06) : 2089 - 2096
  • [2] IMMUNOGENICITY AND SAFETY OF THE CORONOVAC AND BNT162B2 COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES AND HEALTHY ADULTS: COMPARISON OF DIFFERENT VACCINES
    Batibay, S.
    Ulucakoy, R. Kocak
    Gunendi, Z.
    Fidan, I.
    Bozdayi, G.
    Gogus, F. N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1692 - 1692
  • [3] Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong
    Mok, Chris Ka Pun
    Cohen, Carolyn A.
    Cheng, Samuel M. S.
    Chen, Chunke
    Kwok, Kin-On
    Yiu, Karen
    Chan, Tat-On
    Bull, Maireid
    Ling, Kwun Cheung
    Dai, Zixi
    Ng, Susanna S.
    Lui, Grace Chung-Yan
    Wu, Chao
    Amerasinghe, Gaya K.
    Leung, Daisy W.
    Wong, Samuel Yeung Shan
    Valkenburg, Sophie A.
    Peiris, Malik
    Hui, David S.
    RESPIROLOGY, 2022, 27 (04) : 301 - 310
  • [4] A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults
    Miwa Haranaka
    James Baber
    Yoichiro Ogama
    Masako Yamaji
    Masakazu Aizawa
    Osamu Kogawara
    Ingrid Scully
    Eleni Lagkadinou
    Ӧzlem Türeci
    Uğur Şahin
    Philip R. Dormitzer
    William C. Gruber
    Stephen Lockhart
    Nature Communications, 12
  • [5] A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults
    Haranaka, Miwa
    Baber, James
    Ogama, Yoichiro
    Yamaji, Masako
    Aizawa, Masakazu
    Kogawara, Osamu
    Scully, Ingrid
    Lagkadinou, Eleni
    Tuereci, Ozlem
    Sahin, Ugur
    Dormitzer, Philip R.
    Gruber, William C.
    Lockhart, Stephen
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [6] Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications
    Heshin-Bekenstein, Merav
    Ziv, Amit
    Toplak, Natasa
    Hagin, David
    Kadishevich, Danielle
    Butbul, Yonatan A.
    Saiag, Esther
    Kaufman, Alla
    Shefer, Gabi
    Sharon, Orli
    Pel, Sara
    Elkayam, Ori
    Uziel, Yosef
    RHEUMATOLOGY, 2022, 61 (11) : 4263 - 4272
  • [7] Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
    Furer, Victoria
    Eviatar, Tali
    Zisman, Devy
    Peleg, Hagit
    Paran, Daphna
    Levartovsky, David
    Zisapel, Michael
    Elalouf, Ofir
    Kaufman, Ilana
    Meidan, Roni
    Broyde, Adi
    Polachek, Ari
    Wollman, Jonathan
    Litinsky, Ira
    Meridor, Katya
    Nochomovitz, Hila
    Silberman, Adi
    Rosenberg, Dana
    Feld, Joy
    Haddad, Amir
    Gazzit, Tal
    Elias, Muna
    Higazi, Nizar
    Kharouf, Fadi
    Shefer, Gabi
    Sharon, Orly
    Pel, Sara
    Nevo, Sharon
    Elkayam, Ori
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (10) : 1330 - 1338
  • [8] IMMUNOGENICITY AND SAFETY OF THE BNT162B2 MRNA COVID-19 VACCINE IN ADULT PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES AND GENERAL POPULATION: A MULTICENTER STUDY
    Furer, V.
    Eviatar, T.
    Zisman, D.
    Peleg, H.
    Paran, D.
    Levartovsky, D.
    Zisapel, M.
    Elalouf, O.
    Kaufman, I.
    Meidan, R.
    Broyde, A.
    Polachek, A.
    Wollman, J.
    Litinsky, I.
    Meridor, K.
    Nochomovitz, H.
    Silberman, A.
    Rosenberg, D.
    Feld, J.
    Haddad, A.
    Gazitt, T.
    Elias, M.
    Higazi, N.
    Kharouf, F.
    Shefer, G.
    Sharon, O.
    Pel, S.
    Nevo, S.
    Elkayam, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 200 - 201
  • [9] Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults
    Priddy, Frances H.
    Williams, Michael
    Carson, Simon
    Lavender, Brittany
    Mathieson, Julia
    Frampton, Chris
    Moreland, Nicole J.
    McGregor, Reuben
    Williams, Georgia
    Brewerton, Maia
    Gell, Katie
    Ussher, James
    Le Gros, Graham
    VACCINE, 2022, 40 (34) : 5050 - 5059
  • [10] Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
    Frenck, Robert W., Jr.
    Klein, Nicola P.
    Kitchin, Nicholas
    Gurtman, Alejandra
    Absalon, Judith
    Lockhart, Stephen
    Perez, John L.
    Walter, Emmanuel B.
    Senders, Shelly
    Bailey, Ruth
    Swanson, Kena A.
    Ma, Hua
    Xu, Xia
    Koury, Kenneth
    Kalina, Warren V.
    Cooper, David
    Jennings, Timothy
    Brandon, Donald M.
    Thomas, Stephen J.
    Tureci, Ozlem
    Tresnan, Dina B.
    Mather, Susan
    Dormitzer, Philip R.
    Sahin, Ugur
    Jansen, Kathrin U.
    Gruber, William C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03): : 239 - 250
12345